Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2014; 20(8): 2005-2013
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.2005
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.2005
Table 1 Streotactic body radiotherapy for oligo-recurrence within nodal area in colorectal cancer
| Ref. | Study year | No. of patients | Proportion of oligo-nodal metastases | SBRTdose (Gy)1; range (median) | Outcomes | ||
| LC | OS | Severe GI toxicity | |||||
| Bae et al[69] | 2012 | 41 | 44% | 45-60 (48) | 57% (5 yr) | 38% (5 yr) | 7% |
| Kang et al[68] | 2010 | 59 | 53% | 36-51 (42) | 24% (5 yr) | 29% (5 yr) | 3% |
| Kim et al[55] | 2009 | 7 | 100% | 36-51 (48) | (-) | 71% (3 yr) | 14% |
| Kim et al[75] | 2008 | 23 | 100% | 30-51 (39) | 74% (4 yr) | 25% (4 yr) | 4% |
| Hoyer et al[66] | 2006 | 64 | 5% | 45 (45) | 63% (2 yr) | 38% (2 yr) | 5% |
- Citation: Seo YS, Kim MS, Yoo HJ, Jang WI. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer. World J Gastroenterol 2014; 20(8): 2005-2013
- URL: https://www.wjgnet.com/1007-9327/full/v20/i8/2005.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i8.2005